Archive ready

https://www.mhlw.go.jp/stf/newpage_06675.html

April 3, 2026 at 09:30 PM JST•The archive page, viewer, and downloads use this saved version.

April 3, 2026 at 09:30 PM JST·www.mhlw.go.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved page

Open the archived HTML with saved-time metadata attached.

Original URLhttps://www.mhlw.go.jp/stf/newpage_06675.html

StartedApril 3, 2026 at 09:30 PM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page documents the 17th regular opinion exchange meeting on medical device and in vitro diagnostic approval reviews held on July 29, 2019, at PMDA headquarters. The Ministry of Health, Labour and Welfare presented initiatives to accelerate access to innovative medical devices, including the Sakigake Designation System and Conditional Early Approval System. Director General Tarumi emphasized the importance of advanced technologies like genomic medicine and AI in drug development. PMDA's President Fujiwara committed to providing high-quality reviews proportional to examination fees. The meeting aimed to gather stakeholder opinions on regulatory strategies for medical devices and diagnostics.

Screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.